Aptevo Therapeutics
APVO · NASDAQ
$1.62−$0.005 (−0.31%)TodayMarket closed ·
Prev close $1.62
Who owns APVO
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 9.9% of APVO’s shares.
- Niowave Inc5.5%
- GSA Capital Partners LLP1.7%
- Vanguard Capital Management, LLC1.0%
- Geode Capital Management, L.L.C.0.9%
- Next 6 largest institutions0.8%
- All other shareholders90.1%
| Holder | Shares | % of shares |
|---|---|---|
| Niowave Inc | 69.08K | 5.53% |
| GSA Capital Partners LLP | 21.54K | 1.72% |
| Vanguard Capital Management, LLC | 12.71K | 1.02% |
| Geode Capital Management, L.L.C. | 10.82K | 0.87% |
| Vanguard Fiduciary Trust Co | 4.14K | 0.33% |
| Abante Asesores Gestión, S.G.I.I.C., S.A. | 1.76K | 0.14% |
| White (Marvin L) | 1.26K | 0.10% |
| Grant (Grady III) | 1.15K | 0.09% |
| Lamothe (Jeffrey G) | 961 | 0.08% |
| UBS Financial Services, Inc. | 730 | 0.06% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Extended Market Index Fund | 12.71K | 1.02% |
| Fidelity Extended Market Index Fund | 6.38K | 0.51% |
| Abante Quant Value, FI | 1.76K | 0.14% |
| Fidelity Series Total Market Index Fund | 1.55K | 0.12% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of APVO in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Lamothe Jeffrey G. | Option exercise | 961 | — |
| Lamothe Jeffrey G. | Option exercise | 961 | — |
| Kwon SoYoung | Option exercise | 638 | — |
| Kwon SoYoung | Option exercise | 638 | — |
| Huebner Dirk | Option exercise | 638 | — |
| Huebner Dirk | Tax withholding | 156 | $635 |
| Huebner Dirk | Option exercise | 638 | — |
| Grant Grady III | Option exercise | 400 | — |
| Grant Grady III | Option exercise | 400 | — |
| Kunz Barbara Lopez | Option exercise | 400 | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 119.46K
- Days to cover
- 1.71
- % of shares outstanding
- 9.56%
- Average daily volume
- 69.83K
- Change since last report
- −36.4%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.